Does SANDOSTATIN LAR Cause Malignant neoplasm progression? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Malignant neoplasm progression have been filed in association with SANDOSTATIN LAR. This represents 11.3% of all adverse event reports for SANDOSTATIN LAR.
45
Reports of Malignant neoplasm progression with SANDOSTATIN LAR
11.3%
of all SANDOSTATIN LAR reports
30
Deaths
20
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SANDOSTATIN LAR?
Of the 45 reports, 30 (66.7%) resulted in death, 20 (44.4%) required hospitalization, and 1 (2.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SANDOSTATIN LAR. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does SANDOSTATIN LAR Cause?
Death (117)
Diarrhoea (49)
Malaise (49)
Asthenia (45)
Nausea (37)
Weight decreased (37)
Fatigue (36)
Pain (34)
Vomiting (31)
Dyspnoea (29)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which SANDOSTATIN LAR Alternatives Have Lower Malignant neoplasm progression Risk?
SANDOSTATIN LAR vs SANDOZ FENTANYL SYSTEM
SANDOSTATIN LAR vs SAPROPTERIN
SANDOSTATIN LAR vs SAQUINAVIR
SANDOSTATIN LAR vs SARECYCLINE
SANDOSTATIN LAR vs SARGRAMOSTIM